Community Healthcare Trust Incorporated (CHCT)
NYSE: CHCT · IEX Real-Time Price · USD
25.08
-1.45 (-5.47%)
May 1, 2024, 4:00 PM EDT - Market closed
CHCT Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for CHCT stock have an average target of 31, with a low estimate of 26 and a high estimate of 35. The average target predicts an increase of 23.60% from the current stock price of 25.08.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for CHCT stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 2 | 2 | 2 | 2 | 2 |
| Buy | 2 | 2 | 2 | 1 | 1 | 0 |
| Hold | 2 | 2 | 2 | 2 | 2 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 6 | 6 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy → Hold Downgrades $26 | Buy → Hold | Downgrades | $26 | +3.67% | May 1, 2024 |
| Evercore ISI Group | Evercore ISI Group | Hold Maintains $32 → $30 | Hold | Maintains | $32 → $30 | +19.62% | Apr 16, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $40 → $36 | Buy | Maintains | $40 → $36 | +43.54% | Mar 22, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $36 → $35 | Strong Buy | Maintains | $36 → $35 | +39.55% | Jan 16, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $44 → $36 | Strong Buy | Maintains | $44 → $36 | +43.54% | Nov 8, 2023 |
Financial Forecast
Revenue This Year
126.59M
from 112.85M
Increased by 12.18%
Revenue Next Year
138.56M
from 126.59M
Increased by 9.46%
EPS This Year
0.80
from 0.20
Increased by 297.80%
EPS Next Year
0.92
from 0.80
Increased by 15.38%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 133.3M | 150.8M | 171.2M | 200.8M | 224.5M |
| Avg | 126.6M | 138.6M | 159.8M | 195.1M | 218.1M |
| Low | 117.7M | 122.0M | 147.3M | 187.5M | 209.5M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 18.1% | 19.2% | 23.6% | 25.7% | 15.1% |
| Avg | 12.2% | 9.5% | 15.3% | 22.1% | 11.8% |
| Low | 4.3% | -3.6% | 6.3% | 17.3% | 7.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 0.82 | 0.95 | 1.05 |
| Avg | 0.80 | 0.92 | 1.02 |
| Low | 0.76 | 0.88 | 0.98 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 309.5% | 18.8% | 14.4% |
| Avg | 297.8% | 15.4% | 11.1% |
| Low | 282.2% | 10.9% | 6.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.